An evaluation of orally supplemented L-carnitine in premature infants receiving Intralipid 20%.
D000284:Administration, Oral; D002331:Carnitine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004341:Drug Evaluation; D005217:Fat Emulsions, Intravenous / Q000627:therapeutic use*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D050356:Lipid Metabolism; D008297:Male; D009584:Nitrogen / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D005217:Fat Emulsions, Intravenous; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D009584:Nitrogen; D002331:Carnitine